Exagen, Inc. (XGN)
8.42
+0.25
(+3.06%)
USD |
NASDAQ |
Oct 09, 16:00
8.42
0.00 (0.00%)
After-Hours: 20:00
Exagen Cash from Operations (Quarterly) : 3.988M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.988M |
| March 31, 2026 | -10.42M |
| December 31, 2025 | -3.013M |
| September 30, 2025 | 2.944M |
| June 30, 2025 | -2.885M |
| March 31, 2025 | -10.67M |
| December 31, 2024 | 0.363M |
| September 30, 2024 | -2.176M |
| June 30, 2024 | -2.426M |
| March 31, 2024 | -9.04M |
| December 31, 2023 | 8.349M |
| September 30, 2023 | -2.908M |
| June 30, 2023 | -10.15M |
| March 31, 2023 | -9.749M |
| December 31, 2022 | -5.734M |
| September 30, 2022 | -6.682M |
| June 30, 2022 | -11.15M |
| March 31, 2022 | -8.574M |
| December 31, 2021 | -6.047M |
| September 30, 2021 | -5.46M |
| June 30, 2021 | -4.45M |
| March 31, 2021 | -4.312M |
| December 31, 2020 | -3.899M |
| September 30, 2020 | -2.128M |
| June 30, 2020 | -4.756M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.301M |
| December 31, 2019 | -3.927M |
| September 30, 2019 | -1.666M |
| June 30, 2019 | -2.168M |
| March 31, 2019 | -1.95M |
| December 31, 2018 | -1.869M |
| September 30, 2018 | -2.024M |
| June 30, 2018 | -1.978M |
| March 31, 2018 | -3.43M |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | -3.379M |
| September 30, 2015 | -2.898M |
| June 30, 2015 | -2.849M |
| March 31, 2015 | -2.776M |
| December 31, 2014 | -2.443M |
| September 30, 2014 | -2.386M |
| June 30, 2014 | -2.747M |
| March 31, 2014 | -3.197M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -8.30M |
| BioRestorative Therapies, Inc. | -3.808M |
| CareDx, Inc. | 30.60M |
| Natera, Inc. | 54.79M |
| Sera Prognostics, Inc. | -6.311M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.543M |
| Cash from Financing (Quarterly) | -0.37M |
| Free Cash Flow | -7.588M |
| Free Cash Flow Per Share (Quarterly) | 0.1426 |
| Free Cash Flow to Equity (Quarterly) | 2.935M |
| Free Cash Flow to Firm (Quarterly) | 4.646M |
| Free Cash Flow Yield | -3.81% |